Dr. Ramesh Kr. Mehta of Mehta & Mehta Associates (MehtaIP) was recently invited by National Agri-Food Biotechnology Institute (NABI) to speak on “Innovation in Biotechnology: Perspective of Patent Attorney” and interact with NABI and Center of Innovative and Applied Bioprocessing (CIAB)’s scientists on IP related Matters as part of their IPR Workshop held at NABI, Mohali. A few glimpses of the interactive session with NABI and CIAB’s scientists:
Continue reading “IPR Workshop at NABI, Mohali”We are pleased to share that Mehta & Mehta Associates (MehtaIP) has been listed by The Legal 500 (Legalease) in the Legal 500 Asia Pacific rankings 2021 as Leading Firm and our members Dr. Ramesh Kr. Mehta, Ankush Mehta, Abhilasha Niroola and Akshay Mehta have been listed as Recommended Lawyers in the Legal 500 Asia Pacific rankings 2021.
Continue reading “Announcement – Recognition by ‘Legal 500’”We are pleased to share that The Enterprise World’s APAC Special Edition has recognized Dr. Ramesh Kumar Mehta as one of The Most Influential Lawyers in India for the year 2020. Continue reading “Announcement – Dr. Ramesh Kumar Mehta recognized as one of The Most Influential Lawyers in India”
Mehta & Mehta Associates (MehtaIP), India will be attending #INTA2019 in Boston from 17 May 2019 to 22 May 2019. Meet following members from our Firm: Continue reading “INTA 2019 in Boston #Event”
We are pleased to share that World Intellectual Property Forum has recognized Dr. Ramesh Kr. Mehta among top 100 IP Leaders of India.
Mehta & Mehta Associates (MehtaIP) was at World IP Forum from 16th to 18th January 2018 at Hotel Raffles, Dubai. We thank all members of WIPF2018 for their active participation and making it successful! Continue reading “World IP Forum 2018 #WIPF2018”
One of our fond memories – Dr. Ramesh Kr. Mehta being awarded by Hon’ble Dr. A.P.J. Abdul Kalam (Late), the former President of India for his scientific and technical contributions during his tenure as Director General, DRDO and Chairman, SBMT: Continue reading “From the Memory Lane – Award by Hon’ble Dr. A.P.J. Abdul Kalam (Late)”
The provisions of Section 3(d) of the Indian Patents Act excluding the grant of patents on inventions relating to the “mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance” have generated certain myths about processing of such patent applications in India. Continue reading “Protection of Inventions Relating to Pharmaceutical and Like Products”
MehtaIP 